Xeris Biopharma (XERS) News Today $7.75 +0.16 (+2.11%) Closing price 08/22/2025 04:00 PM EasternExtended Trading$7.64 -0.11 (-1.35%) As of 08/22/2025 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock XERS Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Q3 EPS Estimates for Xeris Biopharma Decreased by AnalystAugust 23 at 7:28 AM | marketbeat.comFY2025 EPS Estimate for Xeris Biopharma Increased by AnalystAugust 23 at 2:45 AM | americanbankingnews.comQ3 EPS Estimates for Xeris Biopharma Lowered by AnalystAugust 23 at 2:35 AM | americanbankingnews.comVoss Capital LP Makes New Investment in Xeris Biopharma Holdings, Inc. $XERSAugust 21 at 6:52 AM | marketbeat.comXeris Biopharma Holdings, Inc. (NASDAQ:XERS) Receives $6.58 Average PT from AnalystsAugust 20 at 2:09 AM | americanbankingnews.comDeutsche Bank AG Grows Position in Xeris Biopharma Holdings, Inc. $XERSAugust 19, 2025 | marketbeat.comXeris Biopharma Holdings, Inc. (NASDAQ:XERS) Given Average Rating of "Moderate Buy" by AnalystsAugust 18, 2025 | marketbeat.comXeris Biopharma Holdings, Inc. (NASDAQ:XERS) Director John Johnson Sells 107,500 SharesAugust 17, 2025 | marketbeat.comXeris Biopharma (NASDAQ:XERS) Sets New 52-Week High - Here's WhyAugust 17, 2025 | marketbeat.comJohn Johnson Sells 107,500 Shares of Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) StockAugust 16, 2025 | insidertrades.comHC Wainwright Estimates Xeris Biopharma Q3 EarningsAugust 16, 2025 | marketbeat.comHC Wainwright Comments on Xeris Biopharma Q3 EarningsAugust 16, 2025 | americanbankingnews.comInsider Selling: Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Director Sells 42,500 Shares of StockAugust 15, 2025 | marketbeat.comConnor Clark & Lunn Investment Management Ltd. Purchases 418,139 Shares of Xeris Biopharma Holdings, Inc. (NASDAQ:XERS)August 15, 2025 | marketbeat.comXeris Biopharma Holdings, Inc. (NASDAQ:XERS) Director Sells $309,400.00 in StockAugust 14, 2025 | insidertrades.comXeris Biopharma (NASDAQ:XERS) Rating Increased to Buy at HC WainwrightAugust 14, 2025 | americanbankingnews.comXeris Biopharma's (XERS) "Buy" Rating Reaffirmed at HC WainwrightAugust 13, 2025 | marketbeat.comInformed Momentum Co LLC Grows Stock Position in Xeris Biopharma Holdings, Inc. (NASDAQ:XERS)August 13, 2025 | marketbeat.comXeris Biopharma assumed with a Buy at H.C. WainwrightAugust 12, 2025 | msn.comXeris Biopharma Holdings, Inc. (NASDAQ:XERS) is Knott David M Jr's 7th Largest PositionAugust 12, 2025 | marketbeat.comXeris Biopharma (NASDAQ:XERS) Releases Earnings Results, Beats Expectations By $0.02 EPSAugust 10, 2025 | marketbeat.comXeris Biopharma (NASDAQ:XERS) Upgraded to "Strong-Buy" at Wall Street ZenAugust 10, 2025 | marketbeat.comXeris Biopharma (NASDAQ:XERS) Sees Strong Trading Volume Following Better-Than-Expected EarningsAugust 9, 2025 | marketbeat.comXeris Biopharma Holdings Second Quarter 2025 Earnings: Beats ExpectationsAugust 9, 2025 | finance.yahoo.comXeris Biopharma (NASDAQ:XERS) Hits New 12-Month High After Strong EarningsAugust 8, 2025 | marketbeat.comXeris Biopharma Holdings, Inc. (XERS) Q2 2025 Earnings Call TranscriptAugust 7, 2025 | seekingalpha.comXeris Biopharma Reports Record Financial Results for the Second Quarter 2025 and Raises Full Year Revenue GuidanceAugust 7, 2025 | finance.yahoo.comFederated Hermes Inc. Purchases 685,906 Shares of Xeris Biopharma Holdings, Inc. (NASDAQ:XERS)August 5, 2025 | marketbeat.comXeris Biopharma Holdings, Inc. (NASDAQ:XERS) Sees Large Increase in Short InterestAugust 4, 2025 | marketbeat.com216,228 Shares in Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Bought by XTX Topco LtdAugust 3, 2025 | marketbeat.comGSA Capital Partners LLP Buys 88,892 Shares of Xeris Biopharma Holdings, Inc. (NASDAQ:XERS)August 3, 2025 | marketbeat.comXeris Biopharma (XERS) Expected to Announce Earnings on ThursdayAugust 2, 2025 | marketbeat.comXeris Biopharma to Report Second Quarter 2025 Financial Results on August 7, 2025July 31, 2025 | businesswire.comXeris Biopharma Holdings, Inc. (NASDAQ:XERS) is a favorite amongst institutional investors who own 54%July 31, 2025 | finance.yahoo.comEssex Investment Management Co. LLC Has $4.01 Million Stake in Xeris Biopharma Holdings, Inc. (NASDAQ:XERS)July 29, 2025 | marketbeat.comXeris Biopharma Holdings, Inc. (NASDAQ:XERS) Shares Purchased by Legato Capital Management LLCJuly 24, 2025 | marketbeat.comXeris Biopharma Holdings, Inc. (NASDAQ:XERS) Receives Average Recommendation of "Moderate Buy" from BrokeragesJuly 23, 2025 | marketbeat.comCenterBook Partners LP Cuts Position in Xeris Biopharma Holdings, Inc. (NASDAQ:XERS)July 16, 2025 | marketbeat.comBrown Advisory Inc. Has $630,000 Position in Xeris Biopharma Holdings, Inc. (NASDAQ:XERS)July 15, 2025 | marketbeat.comXeris Biopharma Holdings, Inc. (XERS) - Yahoo FinanceJuly 10, 2025 | finance.yahoo.comXeris Biopharma (NASDAQ:XERS) Trading 7.4% Higher - Time to Buy?July 9, 2025 | marketbeat.comXeris Biopharma Holdings, Inc. (NASDAQ:XERS) Receives Consensus Rating of "Moderate Buy" from AnalystsJune 28, 2025 | marketbeat.comXeris Biopharma: Great Numbers, Great Technologies, And Suitable For Long-Term InvestingJune 18, 2025 | seekingalpha.comXeris Biopharma (NASDAQ:XERS) Trading Up 8.4% on Insider Buying ActivityJune 17, 2025 | marketbeat.comXeris Biopharma Holdings, Inc. (NASDAQ:XERS) Insider Kevin Mcculloch Buys 25,000 SharesJune 17, 2025 | insidertrades.comKevin Mcculloch Purchases 25,000 Shares of Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) StockJune 16, 2025 | marketbeat.comLeerink Partnrs Estimates Xeris Biopharma FY2025 EarningsJune 9, 2025 | marketbeat.comLeerink Partnrs Cuts Earnings Estimates for Xeris BiopharmaJune 6, 2025 | marketbeat.comMackenzie Financial Corp Buys 106,153 Shares of Xeris Biopharma Holdings, Inc. (NASDAQ:XERS)June 4, 2025 | marketbeat.comXeris Unveils Strategy for Long-Term Growth and Value Creation at 2025 Analyst & Investor DayJune 3, 2025 | finance.yahoo.com Get Xeris Biopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for XERS and its competitors with MarketBeat's FREE daily newsletter. Email Address XERS Media Mentions By Week XERS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. XERS News Sentiment▼0.990.68▲Average Medical News Sentiment XERS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. XERS Articles This Week▼163▲XERS Articles Average Week Get Xeris Biopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for XERS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies CYTK News VKTX News TGTX News KRYS News ACAD News PCVX News AAPG News ACLX News ADMA News ZLAB News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:XERS) was last updated on 8/23/2025 by MarketBeat.com Staff From Our PartnersBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredAmazon’s big Bitcoin embarrassmentBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Xeris Biopharma Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Xeris Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access